comparemela.com

Latest Breaking News On - Verastem inc - Page 1 : comparemela.com

Kirby McInerney LLP Announces Investigation of Shareholder Claims Against Verastem, Inc. (VSTM)

The law firm of Kirby McInerney LLP is investigating potential claims against Verastem, Inc. . The investigation concerns whether Verastem and/or certain of its officers have violated the federal.

Thomasw-elrod
Verastem-inc
Kirby-mcinerney
New-york-based
Attorney-advertising

Kirby McInerney LLP Announces Investigation of Shareholder Claims Against Verastem, Inc. (VSTM)

Kirby McInerney LLP Announces Investigation of Shareholder Claims Against Verastem, Inc. (VSTM)
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Thomasw-elrod
Investigation-of-shareholder-claims-against-verastem-inc
Verastem-inc
Kirby-mcinerney
Shareholder-claims-against-verastem
New-york-based
Attorney-advertising

Verastem (NASDAQ:VSTM) Receives Buy Rating from HC Wainwright

HC Wainwright reissued their buy rating on shares of Verastem (NASDAQ:VSTM – Free Report) in a report issued on Tuesday morning, Benzinga reports. The brokerage currently has a $17.50 target price on the biopharmaceutical company’s stock. A number of other research firms also recently commented on VSTM. Royal Bank of Canada reaffirmed an outperform rating […]

Canada
United-states
Verastem-inc
Royal-bank
Sectoral-asset-management-inc
Vanguard-group-inc
Cannon-global-investment-management
Verastem-company-profile
Citigroup-inc
Free-report
Moderate-buy

Royal Bank of Canada Trims Verastem (NASDAQ:VSTM) Target Price to $16.00

Verastem (NASDAQ:VSTM – Free Report) had its target price decreased by Royal Bank of Canada from $32.00 to $16.00 in a research note released on Tuesday morning, Benzinga reports. Royal Bank of Canada currently has an outperform rating on the biopharmaceutical company’s stock. Several other brokerages also recently commented on VSTM. HC Wainwright reiterated a […]

Canada
United-states
Sectoral-asset-management-inc
Citigroup-inc
York-mellon-corp
Royal-bank
International-assets-investment-management
Verastem-inc
Free-report
Moderate-buy
Stock-down

Alliance Global Partners Cuts Verastem (NASDAQ:VSTM) Price Target to $20.00

Verastem (NASDAQ:VSTM – Free Report) had its target price trimmed by Alliance Global Partners from $34.00 to $20.00 in a research note released on Wednesday morning, Benzinga reports. The brokerage currently has a buy rating on the biopharmaceutical company’s stock. Several other equities research analysts have also issued reports on VSTM. Royal Bank of Canada […]

Canada
United-states
Verastem-inc
Citigroup-inc
Sectoral-asset-management-inc
Royal-bank
International-assets-investment-management
York-mellon-corp
Alliance-global-partners
Free-report
Moderate-buy

vimarsana © 2020. All Rights Reserved.